The Valley Desk

NCT04313881 · Interventional trial

Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS)

Overall registry status Terminated

Phase 3

Conditions Myelodysplastic Syndromes

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov